BioCentury
ARTICLE | Clinical News

Kiobrina: Completed Phase III enrollment

March 3, 2014 8:00 AM UTC

Swedish Orphan disclosed in its 2013 financial results that it completed enrollment in a double-blind, placebo-controlled, European Phase III trial evaluating Kiobrina added to preterm formula or past...